Previous Article | Next Article 
Journal of Virology, November 1998, p. 9121-9130, Vol. 72, No. 11
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Receptor Binding Sites and Antigenic Epitopes on
the Fiber Knob of Human Adenovirus Serotype 3
Herbert
Liebermann,1,*
Renate
Mentel,1
Ulrike
Bauer,1
Patricia
Pring-Åkerblom,2
Rudolf
Dölling,3
Susanne
Modrow,4 and
Werner
Seidel1
Institut für Medizinische
Mikrobiologie, Ernst-Moritz-Arndt-Universität Greifswald, D-17487
Greifswald,1
Institut für
Virologie und Seuchenhygiene, Medizinische Hochschule Hannover, D-30623
Hanover,2
Biosyntan, D-13125
Berlin,3 and
Institut für
Medizinische Mikrobiologie und Hygiene, Universität
Regensburg, D-93042 Regensburg,4 Germany
Received 19 February 1998/Accepted 8 July 1998
 |
ABSTRACT |
The adenovirus fiber knob causes the first step in the interaction
of adenovirus with cell membrane receptors. To obtain information on the receptor binding site(s), the interaction of labeled cell membrane proteins to synthetic peptides covering the adenovirus type 3 (Ad3) fiber knob was studied. Peptide P6 (amino acids [aa] 187 to
200), to a lesser extent P14 (aa 281 to 294), and probably P11 (aa 244 to 256) interacted specifically with cell membrane proteins, indicating
that these peptides present cell receptor binding sites. Peptides P6,
P11, and P14 span the D, G, and I
-strands of the R-sheet,
respectively. The other reactive peptides, P2 (aa 142 to 156), P3 (aa
153 to 167), and P16 (aa 300 to 319), probably do not present real
receptor binding sites. The binding to these six peptides was inhibited
by Ad3 virion and was independent of divalent cations. We have also
screened the antigenic epitopes on the knob with recombinant Ad3
fiber, recombinant Ad3 fiber knob, and Ad3 virion-specific antisera by
enzyme-linked immunosorbent assay. The main antigenic epitopes were
presented by P3, P6, P12 (aa 254 to 269), P14, and especially the
C-terminal P16. Peptides P14 and P16 of the Ad3 fiber knob were able to
inhibit Ad3 infection of cells.
 |
INTRODUCTION |
Human adenoviruses (Ad) have been
divided into six subgenera, A to F, according to their biologic,
immunologic, biochemical, and oncogenic properties (45, 51).
Ad3, Ad7, and Ad21 of subgenus B:1 cause outbreaks of acute
respiratory infections. Ad are icosahedral, nonenveloped,
double-stranded DNA viruses. The fiber is located at the 12 vertices of
the viral icosahedron. It is responsible for the specific high-affinity
binding of virions to the cell receptor(s) and thus determines the
tissue tropism. This is essential for the use of Ad as vectors for gene
therapy (22, 24, 25). The fiber of Ad3 is already well
characterized. The amino acid sequence of the fiber protein of Ad3 was
published previously (46). The length of the fiber of human
Ad3, terminating in a knob, is 16 nm (6, 44). The N terminus
of the fiber polypeptide chains, located in the tail region, interacts
with the penton base, and the C terminus is in the knob (or head)
(9, 52). The fibers are trimers of identical subunits
(1, 50).
The first step in the interaction of the Ad with a permissive cell is
the attachment of the virus, via the head domain of the fiber, to a
primary cell plasma membrane receptor and via the RGD sequence motif of
the penton base to a second receptor (2, 3, 11, 20, 30, 31, 33,
38, 49). The primary receptor of Ad of subgroup C is different
from that of subgroup B (7, 48). Despite the extensive study
of the fiber, it is not known which sequence motifs of the fiber knob
of Ad3 participate in the virus attachment and which are antigenic
epitopes. The receptor binding sites on the fiber head of Ad2 are
also unknown. Only antigenic and partly immunogenic determinants have
been evaluated, using synthetic peptides (15, 28).
Recently, Mei and Wadell (34) used recombinant fiber
proteins, synthetic peptides, and the corresponding antisera for the
determination of antigenic and immunogenic epitopes. For the
localization of the hemagglutination binding domain on subgenus
B:2 Ad fibers, they used mutagenesis of the fibers. Eiz and
Pring-Åkerblom (13) localized the type-specific determinant
on the fibers of Ad9 and Ad19, also with mutated recombinant fiber
proteins. It is known that the soluble Ad fiber and fiber knob are able
not only to inhibit the attachment of Ad to cells (29, 30,
39) but also to inhibit the infection (7, 19). However, it is unknown whether selected peptide sequence motifs of the
Ad fiber knob are also able to inhibit the Ad infection of cells.
For the determination of receptor binding sites, synthetic peptides
should be useful. The requirement for an interaction of peptides with
receptor proteins or antibodies is normally the existence of continuous
(linear) determinants. Peptide scanning (pepscan) has been used up to
now for the mapping of linear epitopes and recently also of
discontinuous epitopes (17, 37, 42). We decided to use
the pepscan for the mapping of receptor binding sites on the Ad3 fiber
knob.
In this study, we evaluated the reaction of labeled cell plasma
membrane proteins with synthetic peptides covering the knob of the Ad3
fiber and compared it to the binding of polyclonal antibodies specific
for the fiber knob, fiber, and/or virus, also by using a pepscan system
(4, 14, 47). The aim was the determination of possible cell
receptor binding sites and of antigenic epitopes on the fiber knob.
We also studied the influence of some of these peptides on Ad infection
of cells.
 |
MATERIALS AND METHODS |
Fiber knob-derived peptides.
In addition to the already
available 15- to 20-mer peptides of the Ad3 fiber knob, P8 (amino acids
[aa] 210 to 224), P13 (aa 267 to 283), P15 (aa K-291 to 306), and P16
(aa 300 to 319) (Table 1) (28), three peptides (P6 [aa 187 to 200], P11 [aa 244 to 256], and P14 [aa 281 to 294]) were
selected on the basis of the structural model of the Ad5 fiber and by
amino acid sequence comparisons (53, 54). They were
synthesized by a solid phase synthesizer and purified by preparative
high-pressure liquid chromatography as previously described
(28). The other overlapping 13- to 17-mer peptides were
synthesized simultaneously (SYRO robotic system; MultiSynTec GmbH,
Bochum, Germany) on Tentagel RAM resin (Rapp Polymere GmbH,
Tübingen, Germany) by means of the 9-fluorenylmethoxycarbonyl (Fmoc) strategy. Peptides were synthesized at the C terminal as amides
and modified at the N terminal with biotin-6-aminohexane carbonic acid.
They were analyzed by analytical reversed-phase high-pressure liquid
chromatography and by matrix-assisted laser desorption/ionization
time-of-flight (MALDI-TOF) mass spectrometry (MALDI I;
Shimadzu/Kratos).
Cells.
For cell membrane protein (CM) preparations, FL or
HeLa cells were grown in monolayer cultures in Eagle's minimal
essential medium containing 7 to 10% heat-inactivated fetal calf serum
and subcultured every 5 to 6 days. These cells in medium containing 2%
fetal calf serum were also used for virus propagation.
Labeling of cell surface proteins with biotin or DIG and their
preparation.
The labeling and preparation steps were performed
similarly to those described by De Verdugo et al. (10) and
Krah (23). The cell monolayers were washed with
phosphate-buffered saline (PBS) (pH 7.2) and incubated in 10 mM EDTA in
PBS for 12 min at 37°C, and the rest of the monolayer was scraped
off, washed twice with PBS, and resuspended in PBS (approximately
4 × 107 cells per ml); then 70 µl of freshly
prepared D-biotinoyl-
-amidocaproic acid
N-hydroxysuccinimide ester or 82 µl of freshly prepared
digoxigenin-3-O-succinyl-
-aminocaproic acid-N-hydroxysuccinimide ester (DIG-NHS) (Boehringer,
Mannheim, Germany) (2 mg per 100 µl of dimethyl sulfoxide) was
slowly added to 1 ml of cells, and the mixture was incubated on ice for
30 min with gentle shaking. Then 10 ml of 0.05 M Tris in PBS was added,
and the cells were washed twice with PBS. After resuspension (approximately 4 × 106 cells per ml) in lysis buffer
(1.5% octyl glucoside and the protease inhibitors phenylmethylsulfonyl
fluoride [85 µg/ml], aprotinin [1 µg/ml], and leupeptin [2
µg/ml] in PBS) and incubation on ice for 1 h, the lysate was
centrifuged at 400 × g for 5 min at 4°C to remove
nuclei and large cell debris. The supernatant was then centrifuged at
100,000 × g for 20 min to 1 h at 4°C, and
appropriate dilutions of the supernatant were used as cell membrane
proteins for peptide scanning. For unlabeled cell membrane protein
preparations, higher concentrations of washed cells were resuspended in
lysis buffer (approximately 4 × 107 cells per ml),
incubated, and centrifuged. After dilution of the sample and separation
of the octyl glucoside by Sephadex G-25 (Pharmacia, Freiburg, Germany)
gel filtration, a calculated dilution was used for specific blocking
experiments (see below).
Radioactive labeling of cell proteins.
For
[35S]methionine-[35S]cysteine labeling,
25-cm2 flasks with confluent FL or HeLa cell cultures were
washed three times with PBS (pH 7.4) and 2 ml of methionine and
cysteine-free medium and ca. 40 µCi of
[35S]methionine-[35S]cysteine (specific
activity, 1,175 Ci per mmol) (NEN, Du Pont) were added. After
incubation overnight at 37°C, the cells were collected for membrane
protein preparation as described above.
Antigens for antiserum production.
Virus, propagated on FL
or HeLa cells, was purified by pretreatment with Freon or chloroform
and two or three CsCl density gradient centrifugations (28).
After expression in Escherichia coli with the pQE31 or pQE32
vector (Qiagen, Hilden, Germany) as recently reported (41),
recombinant Ad3 fiber knob (rFK3) and Ad7 fiber knob, tagged with six
histidine were purified by metal affinity chromatography. We used the
native conditions as described by the manufacturer (Clontech,
Heidelberg, Germany). The primers for the Ad7 fiber knob were
GGACTTACATTCAATTC (forward) and TCAGTCGTCTTCTCTAA
(reverse); the other primers are described by Pring-Åkerblom et
al. (41). Natural Ad2 fiber was purified from infected HeLa
cells by chromatography as described previously (36).
Western blot analysis.
The samples of rFK3 and recombinant
Ad7 fiber knob (rFK7) were verified by a combined denaturing (boiled in
1% sodium dodecyl sulfate [SDS])-nondenaturing (unboiled samples)
SDS-polyacrylamide gel electrophoresis (PAGE) followed by Western blot
analysis by standard techniques (8, 26). Briefly, proteins
were electrotransferred onto a nitrocellulose membrane (Bio-Rad,
Munich, Germany), which was blocked in Super Block (Pierce, Rockford,
Ill.) and incubated with mouse-anti-RGS six-histidine serum (Qiagen)
for 1 h. The serum was diluted 1:1,000 to 1:2,000 with 10% Super
Block in PBS. The reaction was detected with peroxidase-conjugated
anti-mouse immunoglobulin (Amersham, Braunschweig, Germany) and the ECL
chemiluminescence kit (Amersham).
Antisera.
Rabbit polyclonal sera directed against the Ad3
virion were produced by two immunizations of rabbits with purified
virus (10 µg per injection) together with Freund's complete and
incomplete adjuvants. The anti-recombinant Ad3 fiber rabbit serum was a
generous gift from J. Chroboczek, Grenoble, France. It was
produced by using purified Ad3 fiber, expressed by recombinant
baculovirus (1). Polyclonal antibodies against rFK3 were
obtained by repeated rabbit immunization with rFK3. Anti-Ad2 fiber
serum was prepared with purified Ad2 fiber.
ELISA.
The enzyme-linked immunosorbent assay (ELISA) was
performed as previously described (28). Briefly, the wells
of polystyrene microplates with high adsorption capacity (Greiner,
Frickenhausen, Germany) were coated with approximately 50 µl of
peptides in water (0.3 nmol per well) and incubated at 37°C overnight
to dryness. After nonspecific blocking with 1% fetal calf serum or
Super Block, duplicate samples of three or four serial dilutions of
antisera specific for Ad3, recombinant Ad3 fiber, or rFK3 were tested
with horseradish-peroxidase-labeled anti-rabbit immunoglobulin G
(Amersham) as the second antibody and
o-phenylenediamine-H2O2 as a
substrate. After the enzyme reaction was stopped with 0.85 M
H2SO4, the optical density was measured at 492 nm. Preimmune serum dilutions were included as controls. The
experiments were carried out in duplicate or triplicate.
Binding of CM to peptides.
When biotinylated CM were tested
instead of antisera, only unbiotinylated peptides were preadsorbed and
three serial dilutions (1:300 to 1:2,700) of the stock solution of
labeled cell surface proteins were added to the wells, which were then
incubated for 2 h at room temperature (RT) or overnight at 4°C.
For dilution, blocking buffer in PBS (Super Block) containing 1 mM
MgCl2, 1 mM MnCl2, and protease inhibitors as
mentioned above or the protease inhibitor cocktail complete, EDTA
free (Boehringer), was used. Horseradish peroxidase-labeled
streptavidin (Amersham) was used with
o-phenylenediamine for the detection. To test the binding of
DIG-labeled cell surface proteins to all the immobilized peptides, anti-DIG antibody from sheep (Fab fragments), conjugated with horseradish peroxidase (Boehringer), was used.
[35S]methionine-[35S]cysteine-labeled
cell proteins with 30,000 to 60,000 cpm per well were also incubated
for 2 h at RT with preadsorbed peptides; then the first and second
supernatants obtained after rinsing with 50 µl of PBS per well were
pooled. The washing buffer used after this (two lots of 240 µl per
well) was discarded. The activity of the unadsorbed proteins was
measured with Rotiscint, eco plus (Fa. Roth, Karlsruhe, Germany) in a
liquid scintillation counter. After incubation with 0.5 M NaOH and
drying on filter paper, the peptide-bound activity was determined by
counting in toluene-based scintillation counters.
Analogous to the measurements with DIG-labeled CM, mixtures of labeled
and unlabeled CM (more than the 50-fold concentration of labeled
protein) were used in parallel, or the unlabeled CM were preincubated
for 2 h at RT. The measured bound activity was in this case the
value for the nonspecific binding (adsorption). The difference between
the measured bound activities without and with unlabeled CM is the
specific bound activity. However, only the specific bound activity was
evaluated as positive, if the quotient of the values without and with
blocking by unlabeled CM was
2. In a second step, the binding of
labeled CM to selected peptides was measured after their preincubation
with Ad3 virion for 1 h at RT.
Focus reduction assay.
A focus reduction assay in two
modifications was conducted. The method was similar to one
recently described (35). In brief, dilutions of the peptides
were mixed with 50 µl of FL cells (300,000 cells/ml) in chamber
slides for tissue culture (Lab Tek, Nunc). After incubation for 30 min
at 37°C, 50 µl of Ad suspension was added. For the serum
neutralization test, 100 µl of antiserum dilutions and 50 µl of Ad
suspension were incubated for 2 h. After this, 50 µl of the
respective cell suspensions were added. In both experiments, the virus
doses were selected in such a way that the virus control was
represented by approximately 40 FFU. Cultures were incubated for
48 h at 37°C. After drying, fixation, and staining with
fluorescein isothiocyanate-labeled antibodies against Ad, the number of
foci was counted with a fluorescence microscope.
 |
RESULTS |
Characterization of the recombinant Ad3 fiber knob protein and the
corresponding antibody preparation.
Before pepscan was performed,
it was necessary to characterize our recently produced recombinant Ad3
fiber knob antigen and the corresponding antiserum. The rFK3
preparation was purified by affinity chromatography and then analyzed
by SDS-PAGE. As shown in Fig. 1A, a
protein of 23 kDa was identified under denaturing conditions. The
23-kDa band represents the monomeric form of the fiber knob. This
result agreed with the molecular mass predicted by the amino acid
sequence of the fiber knob (including the RGS six-histidine
epitope) (41). Under nondenaturing conditions, a
component of approximately 53 kDa was obtained. Instead of the 53-kDa
band, a 66- to 69-kDa band was expected as a trimeric form. The
Western blot displayed a reaction with the monomeric and the oligomeric
rFK3 (Fig. 1B). The oligomeric protein was used as the immunogen for
the preparation of polyclonal antibodies. The focus reduction assay was
performed to determine the neutralizing capacity of the antisera
directed against rFK3 and Ad3 virion, which were to be used in the
pepscan. These antisera were compared with anti-recombinant Ad7 fiber
knob serum and an antiserum against the natural Ad2 fiber. All antisera
displayed neutralization titers of >2,000 (Fig.
2).

View larger version (41K):
[in this window]
[in a new window]
|
FIG. 1.
Analysis of purified recombinant fiber knob
proteins. (A) SDS-PAGE of the affinity-purified rFK3 and rFK7;
the samples in 0.1% SDS were not boiled before electrophoresis (10%
polyacrylamide gel). The gel was stained with Coomassie brilliant
blue. Lanes: M, molecular size markers; 1 and 2, rFK3 samples 1 and 2;
3 and 4, rFK7 samples 1 and 2. (B) Immunoblot reaction of rFK3
with mouse-anti-RGS six-histidine serum (1:2,000) and detection by
using with peroxidase-conjugated anti-mouse immunoglobulin and the ECL
kit. Lanes: 1, monomer of rFK3 (23 kDa) (boiled before SDS-PAGE in 1%
SDS sample buffer); 2, oligomer of rFK3 (53 kDa) (without boiling). The
sizes of the markers are indicated in kilodaltons.
|
|

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 2.
Neutralization assay. Focus reduction by antibodies
against rFK3 is shown in comparison with rFK7-, Ad2 fiber (F2)-, and
Ad3 virion-specific sera and preimmune serum, tested with the
respective homologous virus. Standard deviations SD were within 6 to
12%. The assay was performed as described in Material and Methods.
|
|
Antigenic epitopes and receptor binding sites on the Ad3 fiber
knob.
Epitope mapping permits location of all the (linear)
epitopes (43) in the FK3 protein. One method for
epitope mapping based on ELISA involves the use of overlapping
peptides, spanning the entire amino acid sequence of FK3, and
antisera directed to this protein.
The domain of a viral surface protein which interacts with a cellular
receptor may be defined as a receptor binding site.
To identify such
sites, pepscan could be applied. We extended
this method, normally
used for the epitope mapping, to measure
the binding of labeled
cell surface proteins to overlapping peptides
derived from the
FK3 protein. By this method, it should be possible
to obtain a map
of possible receptor binding sites. We preferred
the use of labeled CM
preparations to the use of labeled cells,
because there may be more
steric hindrance in the binding of whole
cells than of membrane protein
to small peptides, bound on a solid
phase.
Originally, 186 overlapping 9-mer peptides of the FK3 protein, bound to
pins, were evaluated for their reaction with antibodies.
However,
the values of optical density (extinction) obtained with
the antisera
were not higher than twice the values of the preimmune
sera as
controls (data not shown). Therefore, free 13- to 20-mer
overlapping
peptides also spanning the entire amino acid sequence
of FK3 were used
for further analyses.
At first, peptides P6, P8, P11, and P13 to P16 (Table
1) were evaluated for the reactivity with
antisera and cell membrane
proteins. Peptides P6, P11, and P14 were
selected because they
span the D, G, and I

-strands (see Fig.
6). These regions should
participate in the binding of the cell
receptor(s) (
53,
54).
The antibodies specific to
recombinant Ad3 fiber and Ad3 virion
reacted with the seven peptides in
the ELISA (data not shown).
The peptides were then tested with labeled
cell proteins. Two
kinds of labeling of the proteins were performed,
biotinylation
and metabolic labeling with
[
35S]methionine-[
35S]cysteine.
Peptides P6, P11, and P14 displayed a stronger reactivity
with
biotinylated FL cell surface proteins than the others did
(Fig.
3A). The reactivity pattern was very
similar when
[
35S]methionine-[
35S]cysteine-labeled
FL cell proteins were used (Fig.
3B). After
these promising
results, experiments were extended to include
all further peptides
derived from the Ad3 fiber knob (Table
1).

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 3.
Reactivity of selected peptides derived from the Ad3
fiber knob with labeled FL CM. (A) Binding of biotinylated FL cell
surface proteins to the immobilized peptides (0.25 µg of 15-mer
peptide per well). Horseradish peroxidase-labeled streptavidin was used
together with o-phenylenediamine for the detection, as
described in Materials and Methods. OD, optical density. (B) Bound
activity of
[35S]methionine-[35S]cysteine-labeled
FL cell proteins. Radioactively labeled proteins were added at 50,000 cpm per well. Each datum point is the average for four wells.
|
|
Map of antigenic epitopes of the Ad3 fiber knob.
All
the overlapping peptides (Table 1) were immobilized on
microplates and the reactivity with the antisera specific to
recombinant Ad3 fiber, recombinant Ad3 fiber knob, and Ad3 virion were
evaluated in ELISAs. As shown in Fig. 4,
the antiserum directed against the recombinant Ad3 fiber protein
reacted strongly with peptides P3, P6, P12, P14, and P16. These
peptides contain main epitopes. The binding of anti-Ad3 virion
antibodies was generally low. This effect was expected, because the 12 fibers on the virion represent only ca. 1/100 of the mass of the virion
protein, and consequently the induced antibody level can be very low.
However, the reactivity patterns with anti-Ad3 virion and
anti-recombinant Ad3 fiber sera were similar. Surprisingly, P16, which
showed the strongest reactivity with the recombinant Ad3 fiber-specific
serum, did not react with antibodies directed to the Ad3 virion. Taking
into account the generally low values with anti-Ad3 virion antibodies,
the data indicate that there may be a minor difference in the
conformations of the recombinant Ad3 fiber and the natural viral
counterpart used for antisera production. The reaction pattern with
rFK3-specific antibodies was different from the others, especially for
P15. This serum reacted only with P10, P12, P15, and P16, suggesting that the conformation of the rFK3, expressed in E. coli is
not identical to that of the natural FK3 or to that of the knob of the
Ad3 fiber protein, expressed by recombinant baculovirus. The biological
variability of the rabbits used for antisera production could also have
influenced the reactivity pattern.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 4.
Antigenic epitopes on FK3. (A) Reaction of anti-rFK3
antibody (1/600), anti-recombinant Ad3 fiber (rF3) (1/900), and
anti-Ad3 virion (1/100) sera in the ELISA with overlapping FK3 peptides
P1 to P16 immobilized on microplates (0.5 µg of a 15-mer peptide per
well). OD, optical density. Preimmune sera were used at dilutions of
1/100, 1/600 and 1/900. The results shown are an average of three
separate experiments. Only optical densities larger than twice the
value of the preimmune serum are shown. (B) Plot structure of FK3. The
prediction (5, 21) for the secondary protein structure
overlaid with the values for the antigenic index of 1.2 is shown. The
positions of the antigenic peptides are displayed. The sizes of the
letters (of the peptides) correlate with the reactivity. The knob
domain starts at position 134.
|
|
Subsequently, we compared the antigenicities of the peptides
determined in the ELISA by using antibodies against recombinant
Ad3 fiber and the predicted secondary FK3 protein structure overlaid
with the values for the antigenic index of

1.2 (
5,
21).
They corresponded very well (Fig.
4B), indicating that the obtained
map
of antigenic epitopes is probably correct. The different purities
of the peptides did not significantly change the results (data
not
shown). Considering the different purities of the peptides
in these
ELISAs, the quantities of the peptides per well were
changed as
follows: for example, 50 µl of a 15-mer peptide (10
µg/ml) with
90% purity and 90 µl of a 15-mer peptide with 50%
purity were added
to the wells and dried.
Map of receptor binding sites.
Analogous to the mapping of
antigenic epitopes, the binding of labeled FL or HeLa CM to the
immobilized peptides, derived from the Ad3 fiber knob, was
evaluated. For the determination of the specific binding of
viruses to cells, the attachments of the labeled virus were usually
specifically blocked by unlabeled virus in great excess (7, 28,
29). Analogously, the binding of labeled CM should be
blocked by the unlabeled membrane proteins. The specific
bound activity was determined as described in the legend to Fig.
5A. The strong binding of
DIG-labeled HeLa CM to peptides P2, P3, P6, P11, P14, and P16 was
significantly reduced by using unlabeled HeLa-CM or FL-CM. To
distinguish whether the binding of the CM to these peptides was Ad3
virion specific, labeled CM were preincubated with Ad3 virion. An
inhibitory effect by Ad3 virion at a concentration of 0.1 mg/ml could
be detected for P2, P3, and P6. However, Ad3 virion at 0.7 mg/ml
completely prevented the binding of CM to peptides P2, P3, P6, P14, and
P16 and partially prevented binding to P11 (Fig. 5B). The blocking
effect by Ad3 virion means that the binding of the cell surface
proteins to these peptides was Ad3 virion specific. Considering the
different purity of the FK3 peptides, the reactivity pattern was
essentially the same (data not shown). A comparison of the
results with
[35S]methionine-[35S]cysteine cell
proteins and DIG-labeled CM is illustrated in Fig. 5C. Only for
P2 and P11 were the levels different. One reason could be that
during radioactive labeling, many other proteins besides the cell
surface proteins were labeled. Summarizing the results with
DIG-labeled, radioactively labeled, and biotinylated CM, P6, to a
lesser extent P14, and probably P11 interacted specifically with CM,
indicating that these peptides present cell receptor binding sites
of the Ad3 fiber knob. Moreover, the reaction of the cell surface
proteins with P2 and P3 was relatively strong and that with P16 was
(very) moderate. These sequence motifs are in the V-sheet of the knob,
which faces the virus (53, 54) (see Fig. 7). Therefore, P2,
P3, and P16 probably cannot present real receptor binding sites.

View larger version (31K):
[in this window]
[in a new window]

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 5.
Receptor binding sites on FK3. (A) Binding of
DIG-labeled HeLa CM (HeLa-CM) to overlapping FK3 immobilized on ELISA
plates. The experiments were conducted as described in Materials and
Methods. The optical density (OD) of the bound labeled proteins was
measured without and with unlabeled HeLa CM (>50 fold concentration as
labeled). The difference in the values is the peptide-specific binding
of HeLa CM. However, OD values for the specific binding (specif. bind.)
are shown, which were higher than twice the values with unlabeled CM.
These data are averages of two experiments with two values each. The
variation coefficients were within 7 to 15%. The different purity of
the peptides was considered. (B) Binding of DIG-labeled HeLa cell
surface proteins (DIG HeLa-CM) to FK3 peptides without and after
preincubation of DIG HeLa CM with Ad3 virions. Two virion
concentrations, c1 (0.1 mg/ml) and c2 (0.7 mg/ml) were used. The
results are averages of two experiments with two values each. The
different purities of the peptides were considered. (C) Reaction of
[35S]methionine-[35S]cysteine-labeled
FL CM (35S FL-CM) with FK3 peptides in comparison with DIG-labeled HeLa
CM (DIG HeLa-CM). For this, the maximum optical density and the maximum
bound radioactivity obtained in these experiments were set as 100% (at
P3) and the values for the other peptides were displayed as a
percentage of the maximum. The displayed values of the specific binding
of DIG-labeled HeLa CM to the peptides (equimolar without consideration
of the purity) results from three experiments (with two and four values
each, respectively). The displayed reactivities of the immobilized
peptides with radioactively labeled FL CM are means of four values
each.
|
|
It was previously reported by Di Guilmi et al. (
11) that in
the presence of 10 mM EDTA no virus or fiber binding to membrane
proteins was observed in an overlay binding assay. For this reason,
a
possible influence of EDTA on the binding of CM to the FK3 peptides
was
also investigated. In our experiments, 10 mM EDTA did not
prevent the
binding (data not shown).
Comparing the reactivity pattern with antisera and labeled CM,
the antibodies and also FL CM or HeLa CM clearly bound to
peptides
P3, P6, and P14, whereas P11 reacted only with CM and
P16 reacted
strongly only with antiserum. The peptides
presenting possible
receptor binding sites and the main
antigenic epitopes of the
FK3 region are displayed in Fig.
6. Peptides P6, P11, and P14
span the D,
G, and I

-strands, respectively. Surprisingly P13
(aa 267 to 283), which contains nearly the entire H strand, reacted
only weakly
both with labeled CM and with antibodies to recombinant
Ad3 fiber and
Ad3 virion.

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 6.
Primary sequence of FK3 and sequence motifs containing
possible receptor binding sites (underlined) and antigenic main
epitopes (overlined). The ranges of D*, G*, H*, and I* indicate the
-strands of the receptor sheet (53). (Stars were added
for differentiation from the -strands of the V-sheet). The ranges of
A, B, C, and J form the other -sheet, which is partially buried in
the trimeric structure and named the virus (V)-sheet. The small
-strands E and F are parts of the D-G loop. A high intensity in the
reaction is indicated by double lines, and a more moderate reaction is
indicated by full, hatched, or dotted lines.
|
|
Inhibition of the Ad3 infection of cells by fiber knob
peptides.
The fact that peptides of structural proteins of other
viruses can block the virus attachment to cells and also inhibit the infection (16, 27, 55) led to the question whether selected peptide sequence motifs of the Ad3 fiber knob protein may also be able
to inhibit the infection. To determine the influence of FK3 peptides on
Ad infection of cells, a focus assay was performed. First, rFK3 and
rFK7 were tested (Fig. 7A). Both
inhibited only the infectivity of the homologous virus. When
concentrations of fiber protein of
10 µg/ml were used, toxic
effects were observed. The inhibitory effect of the rFK3 was low. The
quality of the rFK7 preparation was obviously higher than that of the
rFK3 preparation. In the following experiments, the inhibitory activity
of the FK3 peptides P6, P11, and P14, which displayed a higher binding
of cell surface proteins and also (except for P11) contained major epitopes, was studied. In addition, P16 was included in the assay, since it showed the highest reactivity with anti-recombinant Ad3 fiber
serum. As a comparison, P13 with a lower binding capacity was included
(Fig. 7B). Only P14 (aa 281 to 294) and P16 (aa 300 to 319) were able
to inhibit the infection at high concentrations in comparison to the
whole fiber knob. When 100 µg of peptides P13 and P16 per ml was
used, toxic effects were observed. As shown, much higher concentrations
of peptides than of fiber protein were necessary to inhibit the
infection. For 50% reduction of the focus number by P14, approximately
30 µg of peptide per ml was necessary, in contrast to approximately 3 µg of rFK3 per ml and 0.3 µg of rFK7 per ml. This is 130- to
1,300-fold higher on a molar basis.

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 7.
Influence of recombinant fiber knobs and peptides on Ad
infection of cells. (A) Reduction of the Ad3 and Ad7 infection of FL
cells by recombinant rFK3 and rFK7, respectively. rFK3 and rFK7
inhibited the infection of the homologous virus (rFK3/Ad3 and rFK7/Ad7)
but not that of the heterologous virus (rFK7/Ad3 and rFK3/Ad7). The
recombinant proteins were used after native purification. (B) Influence
of peptides of FK3 on infection by Ad3. The focus reduction assay was
performed as described in Material and Methods. Results are average of
three or two separate experiments; the standard deviation is indicated
for P14 and P16, which are able to inhibit the infection.
|
|
 |
DISCUSSION |
Receptor binding sites.
To obtain information about the
regions of the Ad fiber knob which participate in the binding of the Ad
to the primary receptor(s) of permissive cells, we first investigated
the interaction of labeled cell surface protein and overlapping
chemically synthesized peptides of the fiber knob of Ad3, a member of
subgenus B:1. This approach seems to be applicable for
determining receptor binding sites. We found that three peptides, P6
(aa 187 to 200), P11 (aa 244 to 256), and P14 (aa 281 to 294),
displayed cell membrane protein binding capacity. These peptides span
the D, G, and I
-strands, respectively (Fig. 6). This
corresponds to the prediction of Xia et al. (53) that these
regions could take part in binding of the cell receptor(s). In a
sequence alignment of the Ad3 and Ad5 fiber knobs (data not shown), our
peptide P6 of FK3 (Fig. 5 and 6) corresponded fully to the
C-terminal part of the core motif (aa 445 to 462) of the Ad5
fiber knob, which binds to the major histocompatibility complex class I
alpha 2 domain at the surface of human epithelial and B-lymphoblastoid
cells (20). This suggests that the probability of the
participation of a sequence motif of the FK3 D
-strand is high. In
the structural model of the trimeric knob, the
-strand G is slightly
hidden in a hollow (53, 54). This may make it difficult for
the cell receptor to reach and could mean that not only sequence motifs
of peptide P2 and P3 of the V-sheet of the Ad3 fiber knob but also
sequence motifs of P11 (Fig. 5 and 6) cannot participate in the
receptor binding. On the other hand, the receptor binding site of
rhinoviruses forms a canyon reachable by the receptor,
intercellular cell adhesion molecule 1 (ICAM-1) (18).
As mentioned above, we preferred the use of labeled CM preparations to
labeled cells in the modified pepscan, because there may be more steric
hindrance in the binding of whole cells than of membrane protein to
small peptides, bound on a solid phase. Also, it is easier to handle CM
than whole living cells in the procedures described. After our
experience, it was necessary to use only fresh preparations of CM. We
use now sulfosuccinimidyl biotin (NHSS-biotin) (Pierce) instead of
NHS-biotin, because the sulfo group prevents the passage of the reagent
through the cell membrane. Our methodological variant, using
DIG-labeled instead of biotinylated cell surface proteins, seems
to be nearly optimal, because we can use streptavidin-coated
microplates for biotinylated peptides. Another advantage in comparison
to radioactive labeling is that only the cell surface proteins and not
all the other cell proteins were labeled when we used NHSS-DIG. Our
result that 10 mM EDTA did not prevent the binding of CM to FK3 means
that divalent cations are obviously not necessary for the binding of CM
to the immobilized peptides. This must not contradict the earlier
finding that in the presence of 10 mM EDTA no virus or fiber binding to membrane proteins was observed in an overlay binding assay
(11). Di Guilmi et al. (11) used the trimeric
fiber protein, but we used the monomeric peptides.
Epitopes.
In previous studies, antisera against FK3 peptides
(aa 210 to 225, aa 267 to 283, and aa K-291 to 306) showed
neutralization titers of 32 and 16, indicating that those
peptides may span minor neutralizing epitopes
(28). These immunogenicity results correspond to the
antigenicity determined. Using recombinant fiber proteins, eight
synthesized peptides, and the corresponding antisera, Mei and Wadell
(34) were able to evaluate antigenic and
immunogenic epitopes, together with the hemagglutination
binding domain on Ad fibers of subgenus B:2. They found that an
epitope with low-level immunogenicity is present in the C-terminal
20 aa of the fiber. This corresponds to our previous results describing
low immunogenicity for the highly antigenic C-terminal peptide P16 (aa
300 to 319) of the Ad3 fiber knob (28), which is very
similar in sequence.
Mei and Wadell (
34) mentioned that rabbit antisera against
Ad11p, Ad34a, and Ad35p virions were also analyzed to detect
epitopes and, unfortunately, displayed extremely low levels of
reactivity. For this reason, we optimized the conditions for
using
virion-specific sera, and our anti-Ad3 serum confirmed the
results
with anti-rF3 serum, with the exception of P16 (aa 300 to 319).
Until now, results have been published only concerning epitope
mapping of the Ad2 fiber knob, not of the Ad3 fiber knob
(
15).
A comparison of the amino acid sequences of both virus
types revealed
that the epitopes found by Fender et al.
(
15) correspond well
to the epitopes of the Ad3 fiber
knob (data not shown).
Since we used 13- to 20-mer peptides overlapping by only 4 aa residues,
the resolution of the epitope location was low. However,
the early
experiments involving the pin-bound 9-mer peptides of
Ad3 fiber knob
with an offset of 1 aa gave disappointing results.
The general
disadvantage of such pin- or membrane-bound peptides
is that the purity
of the peptide preparation cannot be determined.
Ad2 and Ad5 use the same primary receptor and therefore may have a very
similar receptor binding site(s) on the fiber knob.
Recently, Hong et
al. (
20) found a corresponding knob region
of Ad5 between
Val 438 and Asp 462 with a core motif (aa 445 to
462) for the
neutralizing monoclonal antibody 1D 6.3. Our initial
results show that
the corresponding peptide (aa 449 to 463) of
the Ad2 fiber knob
contains a main epitope and a receptor binding
site (unpublished
data).
Focus reduction by peptides.
Previous studies have reported
only on the inhibition of infection by fiber proteins (7, 11,
19). Approximately 0.1 µg of the recombinant knob domain of Ad5
per ml reduced the Ad5 infection of human cells by 50%
(19). In our experiments, approximately 0.3 µg of
recombinant Ad7 fiber knob per ml reduced the focus number in HeLa
cells by 50% (Fig. 7A). It was interesting to evaluate peptides in
this field. We found that two of the FK3 peptides may inhibit the
infection (Fig. 7B). However, approximately 30 µg of P14 (aa 281 to
294) per ml (14 µM) was necessary to obtain 50% inhibition of
infection. A possible explanation could be that in contrast to the
peptides, the fiber proteins used were trimeric. An additional reason
could be the incorrect conformation of these peptides compared with the
conformation of these sequence motifs in the whole trimeric fiber
knob protein. As mentioned by Porta and Lomonossoff
(40), free peptides can adopt a variety of conformations, most of which will not exist in their native environment.
In comparison, about 20 µM RGD-containing peptide of VP1 of
foot-and-mouth disease virus and approximately 5 µM selected peptides
of the fusion protein of human parainfluenza virus were needed
for 50%
plaque reduction (
27,
55). It is also interesting
that to
protect cattle against foot-and-mouth disease virus, a
1,000-fold more
immunogenic tandem peptide of VP1 in comparison
to the inactivated
virus was necessary (
12). A common reason
for these
findings is probably the different conformations of
free peptides and
the corresponding sequence motifs in the viral
proteins.
Summarizing, we conclude that the epitope mapping
serotype-specific epitopes should be determined. The evaluated
receptor
binding sites also give information that will be useful for
the
construction of new vehicles for the gene therapy. First, the
critical part of each binding site should be determined. We are
currently producing antisera against peptides P6, P12 and P14,
presenting probable receptor binding sites and/or strong(er) antigenic
determinants to evaluate the blocking effect on the virus attachment
or
the neutralization. The determination of receptor binding sites
and
antigenic epitopes on the fiber knobs of Ad2 and Ad5 of
subgenus
C and of Ad8 and Ad15 of subgenus D is under
way. Future studies
will also investigate whether stimulated
lymphocytes (
36) use
the same receptor binding sites and
receptor molecules as HeLa
or FL cells.
 |
ACKNOWLEDGMENTS |
We thank J. Chroboczek, Institut de Biologie Structurale,
Grenoble, France, for the gift of anti-recombinant Ad3 fiber serum; M. Liebermann and M. Wolfgramm for excellent technical assistance; F. Kernchen, Biosyntan Berlin-Buch, for the synthesis of pin-bound and
biotinylated peptides; U. Wegner for help in the neutralization test;
and K. Lotz for help in the last pepscans.
This work was supported by grants from the Ministerium für
Kultur, Schwerin (EMAU/12/94), and the Deutsche Forschungsgemeinschaft (Se700/1-3).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Abteilung
Virologie, Institut für Medizinische Mikrobiologie,
Ernst-Moritz-Arndt-Universität Greifswald,
Martin-Luther-Str. 6, D-17487 Greifswald, Germany. Phone:
49-3834-865551. Fax: 49-3834-865568. E-mail:
seidel{at}rz.uni-greifswald.de.
 |
REFERENCES |
| 1.
|
Albiges-Rizo, C.,
A. Barge,
R. W. H. Ruigrok,
P. A. Timmins, and J. Chroboczek.
1991.
Human adenovirus serotype 3 fibre protein: comparison of native and recombinant proteins.
J. Biol. Chem.
266:3961-3967[Abstract/Free Full Text].
|
| 2.
|
Bai, M.,
B. Harfe, and P. Freimuth.
1993.
Mutations that alter an Arg-Gly-Asp (RGD) sequence in the adenovirus type 2 penton base protein abolish its cell-rounding activity and delay virus reproduction in flat cells.
J. Virol.
67:5198-5205[Abstract/Free Full Text].
|
| 3.
|
Bergelson, J. M.,
J. A. Cunningham,
G. Droguett,
E. A. Kurt-Jones,
A. Krithivas,
J. Hong,
M. S. Horwitz,
R. L. Crowell, and R. W. Finberg.
1997.
Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5.
Science
275:1320-1323[Abstract/Free Full Text].
|
| 4.
|
Bichko, V. V.,
S. M. Lemon,
J.-G. Wang,
S. Hwang,
M. M. C. Lai, and J. M. Taylor.
1996.
Epitopes exposed on hepatitis delta virus nucleoproteins.
J. Virol.
70:5807-5811[Abstract/Free Full Text].
|
| 5.
|
Chou, P. Y., and G. D. Fasman.
1978.
Empirical predictions of protein conformation.
Annu. Rev. Biochem.
47:251-276[Medline].
|
| 6.
|
Chroboczek, J.,
R. W. H. Ruigrok, and S. Cusack.
1995.
Adenovirus fiber, p. 39-46.
In
W. Doerfler, and P. Boehm (ed.), The molecular repertoire of adenoviruses I. Springer-Verlag KG, Berlin, Germany.
|
| 7.
|
Defer, C.,
M.-T. Belin,
M.-L. Caillet-Boudin, and P. Boulanger.
1990.
Human adenovirus-host cell interactions: comparative studies with members of subgroups B and C.
J. Virol.
64:3661-3673[Abstract/Free Full Text].
|
| 8.
|
Dernick, R., and J. Heukeshoven.
1989.
Proteins and peptides, p. 261-347.
In
A. Mayr, P. A. Bachmann, B. Mayr-Bibrack, and G. Wittmann (ed.), Virological methods, vol. III. Fischer, Jena, Germany. (In German.)
|
| 9.
|
Devaux, C.,
M.-L. Caillet-Boudin,
B. Jacrot, and P. Boulanger.
1987.
Crystallization, enzymatic cleavage and the polarity of the adenovirus type 2 fiber.
Virology
161:121-128[Medline].
|
| 10.
|
De Verdugo, U. R.,
H.-C. Selinka,
M. Huber,
B. Kramer,
J. Kellermann,
P. H. Hofschneider, and R. Kandolf.
1995.
Characterization of a 100-kilodalton binding protein for the six serotypes of coxsackie B viruses.
J. Virol.
69:6751-6757[Abstract/Free Full Text].
|
| 11.
|
Di Guilmi, A. M.,
A. Barge,
P. Kitts,
E. Gout, and J. Chroboczek.
1995.
Human adenovirus serotype 3 (Ad3) and the Ad3 fiber protein bind to a 130-kDa membrane protein on HeLa cells.
Virus Res.
38:71-81[Medline].
|
| 12.
|
Di Marchi, R.,
G. Brooke,
C. Gale,
V. Cracknell,
T. Doel, and N. Mowat.
1986.
Protection of cattle against foot-and mouth disease by a synthetic peptide.
Science
232:639-641[Abstract/Free Full Text].
|
| 13.
|
Eiz, B., and P. Pring-Akerblom.
1997.
Molecular characterization of the type-specific -determinant located on the adenovirus fiber.
J. Virol.
71:6576-6581[Abstract/Free Full Text].
|
| 14.
|
Estepa, A., and J. M. Coll.
1996.
Pepscan mapping and fusion-related properties of the major phosphatidylserine-binding domain of the glycoprotein of viral hemorrhagic septicemia virus, a salmonid rhabdovirus.
Virology
216:60-70[Medline].
|
| 15.
|
Fender, P.,
A. H. Kidd,
R. Brebant,
M. Öberg,
E. Drouet, and J. Chroboczek.
1995.
Antigenic sites on the receptor-binding domain of human adenovirus type 2 fiber.
Virology
214:110-117[Medline].
|
| 16.
|
Fox, G.,
N. Parry,
P. Barnett,
B. McGinn,
D. Rowlands, and F. Brown.
1989.
The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid).
J. Gen. Virol.
70:1-12[Abstract/Free Full Text].
|
| 17.
|
Geysen, H. M.,
R. H. Meloen, and S. J. Barteling.
1984.
Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid.
Proc. Natl. Acad. Sci. USA
81:3998-4002[Abstract/Free Full Text].
|
| 18.
|
Greve, J. M., and M. G. Rossmann.
1994.
Interaction of rhinovirus with its receptor, ICAM-1, p. 195-213.
In
E. Wimmer (ed.), Cellular receptors for animal viruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 19.
|
Henry, L. J.,
D. Xia,
M. E. Wilke,
J. Deisenhofer, and R. D. Gerard.
1994.
Characterization of the knob domain of the adenovirus type 5 fiber protein expressed in Escherichia coli.
J. Virol.
68:5239-5246[Abstract/Free Full Text].
|
| 20.
|
Hong, S. S.,
L. Karayan,
J. Tournier,
D. T. Curiel, and P. A. Boulanger.
1997.
Adenovirus type 5 fiber knob binds to MHC class I 2 domain at the surface of human epithelial and B lymphoblastoid cells.
EMBO J.
16:2294-2306[Medline].
|
| 21.
|
Jameson, B. A., and H. Wolf.
1988.
The antigenic index: a novel algorithm for predicting antigenic determinants.
Comput. Appl. Biosci.
4:181-186[Abstract/Free Full Text].
|
| 22.
|
Jolly, D.
1994.
Viral vector systems for gene therapy.
Cancer Gene Ther.
1:51-64[Medline].
|
| 23.
|
Krah, D. L.
1989.
Characterization of octyl glucoside-solubilized cell membrane receptors for binding measles virus.
Virology
172:386-390[Medline].
|
| 24.
|
Krasnykh, V. N.,
G. V. Mikheeva,
J. T. Douglas, and D. T. Curiel.
1996.
Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism.
J. Virol.
70:6839-6846[Abstract/Free Full Text].
|
| 25.
|
Krasnykh, V. N.,
I. Dimitriev,
G. Mikheeva,
C. R. Miller,
N. Belousova, and D. T. Curiel.
1998.
Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob.
J. Virol.
72:1844-1852[Abstract/Free Full Text].
|
| 26.
|
Laemmli, U. K.
1970.
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature
227:680-685[Medline].
|
| 27.
|
Liebermann, H.,
R. Dölling,
D. Schmidt, and G. Thalmann.
1991.
RGD-containing peptides of VP1 of foot-and-mouth disease virus prevent virus infection in vitro.
Acta Virol.
35:90-93[Medline].
|
| 28.
|
Liebermann, H.,
R. Mentel,
L. Döhner,
S. Modrow, and W. Seidel.
1996.
Inhibition of cell adhesion to the virus by synthetic peptides of fiber knob of human adenovirus serotypes 2 and 3 and virus neutralization by anti-peptide antibodies.
Virus Res.
45:111-121[Medline].
|
| 29.
|
Liebermann, H.,
U. Bauer,
P. Pring-Åkerblom,
M. Derbas,
R. Mentel,
U. Wegner, and W. Seidel.
1996.
Interaction of recombinant fiber protein of human adenoviruses serotypes Ad2, Ad3, Ad9 and Ad15 with receptors of permissive cells, abstr. PW33/84, p. 202.
In
Abstracts of the Xth International Congress of Virology.
|
| 30.
|
Louis, N.,
P. Fender,
A. Barge,
P. Kitts, and J. Chroboczek.
1994.
Cell-binding domain of adenovirus serotype 2 fiber.
J. Virol.
68:4104-4106[Abstract/Free Full Text].
|
| 31.
|
Mathias, P.,
T. Wickham,
M. Moore, and G. Nemerow.
1994.
Multiple adenovirus serotypes use v integrins for infection.
J. Virol.
68:6811-6814[Abstract/Free Full Text].
|
| 32.
|
Martens, W.,
I. Greiser-Wilke,
T. C. Harder,
K. Dittmar,
R. Frank,
C. Örvell,
V. Moennig, and B. Liess.
1995.
Spot synthesis of overlapping peptides on paper membrane supports enables the identification of linear monoclonal antibody binding determinants on morbillivirus phosphoproteins.
Vet. Microbiol.
44:289-298[Medline].
|
| 33.
|
Mayr, G., and P. Freimuth.
1997.
A single locus on human chromosome 21 directs the expression of a receptor for adenovirus type 2 in mouse A9 cells.
J. Virol.
71:421-418.
|
| 34.
|
Mei, Y.-F., and G. Wadell.
1996.
Epitopes and hemagglutination binding domain on subgenus B:2 adenovirus fibers.
J. Virol.
70:3688-3697[Abstract/Free Full Text].
|
| 35.
|
Mentel, R.,
E. Matthes,
M. Janta-Lipinski, and U. Wegner.
1996.
Fluorescent focus reduction assay for the screening of anti-adenoviral agents.
J. Virol. Methods
59:99-104[Medline].
|
| 36.
|
Mentel, R.,
G. Döpping,
U. Wegner,
W. Seidel,
H. Liebermann, and L. Döhner.
1997.
Adenovirus-receptor interaction with human lymphocytes.
J. Med. Virol.
51:252-257[Medline].
|
| 37.
|
Modrow, S., and H. Wolf.
1990.
Use of synthetic peptides as diagnostic reagents in virology, p. 83-101.
In
M. H. V. van Regenmortel, and A. R. Neurath (ed.), Immunochemistry of viruses II. The bases for serodiagnosis and vaccines. Elsevier Biomedical Press, Amsterdam, The Netherlands.
|
| 38.
|
Persson, R.,
C. Wohlfart,
U. Svensson, and E. Everitt.
1985.
Virus receptor interaction in the adenovirus system. Characterization of the positive cooperative binding of virions on HeLa cells.
J. Virol.
54:92-97[Abstract/Free Full Text].
|
| 39.
|
Philipson, L.,
K. Lonberg-Holm, and U. Pettersson.
1968.
Virus-receptor interaction in an adenovirus system.
J. Virol.
2:1064-1075[Abstract/Free Full Text].
|
| 40.
|
Porta, C., and G. P. Lomonossoff.
1998.
Scope for using plant viruses to present epitopes from animal pathogens.
Rev. Med. Virol.
8:25-41.
[Medline] |
| 41.
|
Pring-Åkerblom, P.,
A. Heim, and F. E. J. Trijssenaar.
1998.
Molecular characterization of hemagglutination domains on the fibers of subgenus D adenoviruses.
J. Virol.
72:2297-2304[Abstract/Free Full Text].
|
| 42.
|
Reineke, U.,
R. Sabat,
D. Volk, and J. Schneider-Mergener.
1996.
Mapping discontinuous epitopes using cellulose-bound peptide libraries.
Immunobiology
196:96.
|
| 43.
|
Rodda, S. J.,
N. J. Maeji, and G. Tribbick.
1996.
Epitope mapping using multipin peptide synthesis, p. 137-147.
In
G. E. Morris (ed.), Epitope mapping protocols. Humana Press Inc., Totowa, N.J.
|
| 44.
|
Ruigrok, R. W. H.,
A. Barge,
C. Albiges-Rizo, and S. Dayan.
1990.
Structure of adenovirus fibre. II. Morphology of single fibres.
J. Mol. Biol.
215:589-596[Medline].
|
| 45.
|
Shenk, T.
1996.
Adenoviridae: the viruses and their replication, p. 2111-2148.
In
B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Virology, vol. 2. Lippincott-Raven Publishers, Philadelphia, Pa.
|
| 46.
|
Signäs, C.,
G. Akusjärvi, and U. Pettersson.
1985.
Adenovirus 3 fiber polypeptide gene: implications for the structure of the fiber protein.
J. Virol.
53:672-678[Abstract/Free Full Text].
|
| 47.
|
Spencer, J. V.,
B. L. Trus,
F. P. Booy,
A. C. Steven,
W. W. Newcomb, and J. C. Brown.
1997.
Structure of the herpes simplex virus capsid: peptide A862-H880 of the major capsid protein is displayed on the rim of the capsomer protrusions.
Virology
228:229-235[Medline].
|
| 48.
|
Stevenson, S. C.,
M. Rollence,
B. White,
L. Weaver, and A. McClelland.
1995.
Human adenovirus serotype 3 and 5 bind to two different cellular receptors via the fiber head domain.
J. Virol.
69:2850-2857[Abstract/Free Full Text].
|
| 49.
|
Tomko, R. P.,
R. Xu, and L. Philipson.
1997.
HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses.
Proc. Natl. Acad. Sci. USA
94:3352-3356[Abstract/Free Full Text].
|
| 50.
|
Van Oostrum, J., and R. M. Burnett.
1985.
Molecular composition of the adenovirus type 2 virion.
J. Virol.
56:439-448[Abstract/Free Full Text].
|
| 51.
|
Wadell, G.,
W. Doerfler,
W. C. Russel, and G. R. Kitchingman.
1994.
Adenoviruses, p. 1-23.
In
R. G. Webster, and A. Granoff (ed.), Encyclopedia of virology, vol. 2. Academic Press, Ltd., London, United Kingdom.
|
| 52.
|
Weber, J. M.,
B. G. Talbot, and L. Delorme.
1989.
The orientation of the adenovirus fiber and its anchor domain. Identified through molecular mimicry.
Virology
168:180-182[Medline].
|
| 53.
|
Xia, D.,
L. J. Henry,
R. D. Gerard, and J. Deisenhofer.
1994.
Crystal structure of the receptor-binding domain of adenovirus type 5 fiber protein at 1.7 A resolution.
Structure
2:1259-1270[Medline].
|
| 54.
|
Xia, D.,
L. J. Henry,
R. D. Gerard, and J. Deisenhofer.
1995.
Structure of the receptor binding domain of adenovirus type 5 fiber protein, p. 39-46.
In
W. Doerfler, and P. Boehm (ed.), The molecular repertoire of adenoviruses I. Springer-Verlag KG, Berlin, Germany.
|
| 55.
|
Yao, Q., and R. W. Compans.
1996.
Peptides corresponding to the heptad repeat sequence of human parainfluenca virus fusion protein are potent inhibitors of virus infection.
Virology
223:103-112[Medline].
|
Journal of Virology, November 1998, p. 9121-9130, Vol. 72, No. 11
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Bauer, U., Flunker, G., Bruss, K., Kallwellis, K., Liebermann, H., Luettich, T., Motz, M., Seidel, W.
(2005). Detection of Antibodies against Adenovirus Protein IX, Fiber, and Hexon in Human Sera by Immunoblot Assay. J. Clin. Microbiol.
43: 4426-4433
[Abstract]
[Full Text]
-
Akalu, A., Liebermann, H., Bauer, U., Granzow, H., Seidel, W.
(1999). The Subgenus-Specific C-Terminal Region of Protein IX Is Located on the Surface of the Adenovirus Capsid. J. Virol.
73: 6182-6187
[Abstract]
[Full Text]